Literature DB >> 31378555

Impact of first episode psychosis treatment on heavy cannabis use: Secondary analysis on RAISE-ETP study.

Karl C Alcover1, Oladunni Oluwoye2, Liat Kriegel1, Sterling McPherson3, Michael G McDonell4.   

Abstract

Entities:  

Year:  2019        PMID： 31378555      PMCID： PMC6718318          DOI： 10.1016/j.schres.2019.07.014

Source DB:  PubMed          Journal:  Schizophr Res        ISSN： 0920-9964            Impact factor:   4.939


× No keyword cloud information.
  11 in total

1.  Comprehensive Versus Usual Community Care for First-Episode Psychosis: 2-Year Outcomes From the NIMH RAISE Early Treatment Program.

Authors:  John M Kane; Delbert G Robinson; Nina R Schooler; Kim T Mueser; David L Penn; Robert A Rosenheck; Jean Addington; Mary F Brunette; Christoph U Correll; Sue E Estroff; Patricia Marcy; James Robinson; Piper S Meyer-Kalos; Jennifer D Gottlieb; Shirley M Glynn; David W Lynde; Ronny Pipes; Benji T Kurian; Alexander L Miller; Susan T Azrin; Amy B Goldstein; Joanne B Severe; Haiqun Lin; Kyaw J Sint; Majnu John; Robert K Heinssen
Journal:  Am J Psychiatry       Date:  2015-10-20       Impact factor: 18.112

2.  Implementation and fidelity assessment of the NAVIGATE treatment program for first episode psychosis in a multi-site study.

Authors:  Kim T Mueser; Piper S Meyer-Kalos; Shirley M Glynn; David W Lynde; Delbert G Robinson; Susan Gingerich; David L Penn; Corrine Cather; Jennifer D Gottlieb; Patricia Marcy; Jennifer L Wiseman; Sheena Potretzke; Mary F Brunette; Nina R Schooler; Jean Addington; Robert A Rosenheck; Sue E Estroff; John M Kane
Journal:  Schizophr Res       Date:  2018-08-20       Impact factor: 4.939

3.  Supported employment and education in comprehensive, integrated care for first episode psychosis: Effects on work, school, and disability income.

Authors:  Robert Rosenheck; Kim T Mueser; Kyaw Sint; Haiqun Lin; David W Lynde; Shirley M Glynn; Delbert G Robinson; Nina R Schooler; Patricia Marcy; Somaia Mohamed; John M Kane
Journal:  Schizophr Res       Date:  2016-09-23       Impact factor: 4.939

4.  Substance abuse and first-episode schizophrenia-spectrum disorders. The Danish OPUS trial.

Authors:  Lone Petersen; Pia Jeppesen; Anne Thorup; Johan Ohlenschlaeger; Gertrud Krarup; Torben Ostergård; Per Jørgensen; Merete Nordentoft
Journal:  Early Interv Psychiatry       Date:  2007-02       Impact factor: 2.732

5.  Cannabis use and the risk of developing a psychotic disorder.

Authors:  Wayne Hall; Louisa Degenhardt
Journal:  World Psychiatry       Date:  2008       Impact factor: 49.548

6.  High-potency cannabis and the risk of psychosis.

Authors:  Marta Di Forti; Craig Morgan; Paola Dazzan; Carmine Pariante; Valeria Mondelli; Tiago Reis Marques; Rowena Handley; Sonija Luzi; Manuela Russo; Alessandra Paparelli; Alexander Butt; Simona A Stilo; Ben Wiffen; John Powell; Robin M Murray
Journal:  Br J Psychiatry       Date:  2009-12       Impact factor: 9.319

7.  Impact of comprehensive treatment for first episode psychosis on substance use outcomes: A randomized controlled trial.

Authors:  Corinne Cather; Mary F Brunette; Kim T Mueser; Steven F Babbin; Robert Rosenheck; Christoph U Correll; Piper Kalos-Meyer
Journal:  Psychiatry Res       Date:  2018-07-24       Impact factor: 3.222

Review 8.  Meta-analysis of the Association Between the Level of Cannabis Use and Risk of Psychosis.

Authors:  Arianna Marconi; Marta Di Forti; Cathryn M Lewis; Robin M Murray; Evangelos Vassos
Journal:  Schizophr Bull       Date:  2016-02-15       Impact factor: 9.306

Review 9.  Association Between Cannabis and Psychosis: Epidemiologic Evidence.

Authors:  Suzanne H Gage; Matthew Hickman; Stanley Zammit
Journal:  Biol Psychiatry       Date:  2015-08-12       Impact factor: 13.382

10.  Effects of continuation, frequency, and type of cannabis use on relapse in the first 2 years after onset of psychosis: an observational study.

Authors:  Tabea Schoeler; Natalia Petros; Marta Di Forti; Ewa Klamerus; Enrico Foglia; Olesya Ajnakina; Charlotte Gayer-Anderson; Marco Colizzi; Diego Quattrone; Irena Behlke; Sachin Shetty; Philip McGuire; Anthony S David; Robin Murray; Sagnik Bhattacharyya
Journal:  Lancet Psychiatry       Date:  2016-08-23       Impact factor: 27.083
View more
  6 in total

1.  Persistent cannabis use among young adults with early psychosis receiving coordinated specialty care in the United States.

Authors:  Leslie Marino; Jennifer Scodes; Talia Richkin; Jean-Marie Alves-Bradford; Ilana Nossel; Melanie Wall; Lisa Dixon
Journal:  Schizophr Res       Date:  2020-05-28       Impact factor: 4.939

2.  Preliminary Evaluation of Washington State's Early Intervention Program for First-Episode Psychosis.

Authors:  Oladunni Oluwoye; Hailey Reneau; Bryony Stokes; Rebecca Daughtry; Elizabeth Venuto; Tenaya Sunbury; Grace Hong; Barbara Lucenko; Bryan Stiles; Sterling M McPherson; Sarah Kopelovich; Maria Monroe-DeVita; Michael G McDonell
Journal:  Psychiatr Serv       Date:  2019-12-18       Impact factor: 3.084

3.  Cannabis use and metabolic syndrome among clients with first episode psychosis.

Authors:  Erik Stiles; Karl C Alcover; Bryan Stiles; Oladunni Oluwoye; Michael G McDonell
Journal:  Early Interv Psychiatry       Date:  2020-09-02       Impact factor: 2.732

4.  Specialised early intervention teams for recent-onset psychosis.

Authors:  Stephen Puntis; Amedeo Minichino; Franco De Crescenzo; Andrea Cipriani; Belinda Lennox; Rachael Harrison
Journal:  Cochrane Database Syst Rev       Date:  2020-11-02

5.  It might be a wonderful opportunity when patients with a psychotic disorder use cannabis.

Authors:  Lieuwe de Haan
Journal:  Psychol Med       Date:  2022-01-25       Impact factor: 7.723

6.  Cannabis use in first episode psychosis: what we have tried and why it hasn't worked.

Authors:  Michael G McDonell; Oladunni Oluwoye
Journal:  BMC Med       Date:  2019-10-28       Impact factor: 8.775
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.